ACS GCI Pharmaceutical Roundtable
  • Home
  • Global Collaboration

Global Collaboration

Integrating green chemistry and engineering into the global pharmaceutical supply chain is a primary objective of the Roundtable. The Roundtable has member companies in India and China, and dedicates resources to workshops, conferences and site visits in these countries.


The Roundtable has sponsored three events in India in partnership with the Green ChemistryTree Foundation and will be sponsoring a third in the fall of 2019.

Upcoming event:

6th Industrial Green Chemistry World – Convention and Ecosystem, October 16-17, 2019.

Outcomes from past events:


The Roundtable will hold its fall member meeting in Beijing and Tianjin, China.

Global Partnerships

IQ Consortium

The IQ Consortium is a pharmaceutical and biotechnology association that aims to advance innovation and quality in the biopharmaceutical industry. The ACS GCI Pharmaceutical Roundtable has worked closely with the IQ Green Chemistry Working Group whose focus is on communication and discussion with regulatory agencies on Green Chemistry as well as communicating to the public about green processes and technologies. In collaboration with the IQ Consortium, the Roundtable has developed the Green Aspiration Level metric and tool.

Seven Important Elements for an Effective Green Chemistry Program: An IQ Consortium Perspective
David K. Leah; John L. Tucker; Ingrid Mergelsberg; Peter J. Dunn; Michael E. Kopach; and Vikram C. Purohit. Org. Process Res. Dev. 2013, 17, 1099−1109. DOI: /10.1021/op400192h

Pharmaceutical Supply Chain Initiative (PSCI)

PSCI is a group of pharmaceutical and healthcare companies who have joined forces to promote responsible supply chain management and better business conditions across the industry. The ACS GCI Pharmaceutical Roundtable has collaborated with PSCI on its India outreach efforts and continues to look for opportunities to collaborate on issues of common concern.


Is the European Union’s legislative approach to chemicals management and is aimed at protecting human health and the environment through the Registration, Evaluation, Authorization and Restriction of CHemicals. There are a variety of issues associated with the REACH legislation that have significant impacts on the Pharmaceutical industry, especially in the area of solvents. The roundtable has organized around these issues to share best practices and provide industry perspective to legislators as appropriate.


The ACS GCI Pharmaceutical Roundtable has long recognized the value of benchmarking to track industry efforts at making bulk active pharmaceutical ingredient manufacturing processes greener. Since 2008, the RT has been collecting process mass intensity data on small molecules (MW < 1000) manufacturing processes in all stages of development at least every two years. These data provide an excellent snapshot of industry progress in the implementation of green chemistry and engineering. In recent years, these efforts have been expanded to benchmarking biopharmaceutical processes for the manufacture of large molecules (MABs, ADCs, etc.).

Copyright © 2019 ACS Green Chemistry Institute Pharmaceutical Roundtable